Existing firing schemes for the firing of three-phase SCR bridge rectifiers used for industrial applications employ equidistant firing pulses. Mostly they consist of six identical phase control ...

Perkins: Renowned for reliable engines that power both residential and industrial generators. Offers a range from 10kVA to over 2000kVA. Cummins: Offers high-performance diesel generators ideal for ...

The company recently launched the Grand Vitara in the Indian market. The SUV got 6 airbags as standard. Customers now have the option to choose a sunroof in the Zeta and Alpha variants, along with the ...

Otsuka Pharmaceutical has shared more detailed data behind its kidney disease drug’s phase 3 win, showing the monoclonal antibody halved patients’ urine protein-to-creatinine ratio (UPCR) levels.

Since the new installments for Deltarune arrived, the game has surged back up the Steam concurrent charts. Currently, there are over 132,400 players in the game, and that’s before 5 PM EDT on a ...

As a result, Canva's image generator, part of its Magic Studio suite, is actually a helpful use of an image generator. Also: The best AI image generators of 2025: Gemini, ChatGPT, Midjourney, and more ...

NAPOLI 3, a phase 3 study of NALIRIFOX in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC): Final overall survival (OS) analysis and characteristics of the long-term survivors.

Moonlake is running phase 3 studies of the nanobody in psoriatic arthritis and advancing the drug candidate toward pivotal trials in psoriasis, palmoplantar pustulosis and axial spondyloarthritis.

This paper presents the design of a multiphase clock generator that can be integrated in a current-mode wideband receiver. This block consists of a ring of dynamic transmission-gate flip-flops, which ...

Google I/O was about a week ago, and if you haven't heard, one of Google's biggest announcements was the company's Veo 3 generative AI model for video. Gone are the days of creepy, low-quality ...

Regeneron Pharmaceuticals and Sanofi announced that their Phase 3 clinical trial, AERIFY-1, showed a significant 27% reduction in moderate to severe exacerbations of COPD in former smokers treated ...